Literature DB >> 19046950

Localization of histamine H4 receptors in the central nervous system of human and rat.

Marina I Strakhova1, Arthur L Nikkel, Arlene M Manelli, Gin C Hsieh, Timothy A Esbenshade, Jorge D Brioni, Robert S Bitner.   

Abstract

Existing data on the expression of H(4) histamine receptor in the CNS are conflicting and inconclusive. In this report, we present the results of experiments that were conducted in order to elucidate H(4) receptor expression and localization in the brain, spinal cord, and dorsal root ganglia (DRG). Here we show that transcripts of H(4) receptor are present in all analyzed regions of the human CNS, including spinal cord, hippocampus, cortex, thalamus and amygdala, with the highest levels of H(4) mRNA detected in the spinal cord. In rat, H(4) mRNA was detected in cortex, cerebellum, brainstem, amygdala, thalamus and striatum. Very low levels of H(4) mRNA were detected in hypothalamus, and no H(4) signal was detected in the rat hippocampus. Fairly low levels of H(4) mRNA were detected in examined peripheral tissues including spleen and liver. Interestingly, strong expression of H(4) mRNA was detected in the rat DRG and spinal cord. Immunohistochemical analysis revealed expression of H(4) receptors on neurons in the rat lumbar DRG and in the lumbar spinal cord. Our observations provide evidence of the H(4) presence in both human and rodent CNS and offer some insight into possible role of H(4) in itch and pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046950     DOI: 10.1016/j.brainres.2008.11.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  53 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

3.  Nothing to sneeze at.

Authors:  Erica Westly
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

Review 4.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

5.  Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  C Ballerini; A Aldinucci; I Luccarini; A Galante; C Manuelli; P Blandina; M Katebe; P L Chazot; E Masini; M B Passani
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 6.  Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.

Authors:  J Sousa-Valente; A P Andreou; L Urban; I Nagy
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

7.  Histamine H4-receptor expression in the brain?

Authors:  Erich H Schneider; Detlef Neumann; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-26       Impact factor: 3.000

8.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 9.  Peripheral and Central Mechanisms of Itch.

Authors:  Xintong Dong; Xinzhong Dong
Journal:  Neuron       Date:  2018-05-02       Impact factor: 17.173

Review 10.  The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology.

Authors:  Fang Wang; Ting-Lin B Yang; Brian S Kim
Journal:  J Invest Dermatol       Date:  2020-04-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.